Session 7: Pharmacogenomics
Bradley Stockard, PharmD, PhD joined the MCW School of Pharmacy in August 2022. He received his PharmD from the University of Missouri – Kansas City School of Pharmacy and PhD in Pharmaceutical Sciences from the University of Florida. He is a graduate of the Clinical Pharmacology T32 Fellowship program which he completed at Children’s Mercy Hospital in Kansas City, MO. He served as Chief Fellow from 2021-2022. During his fellowship, he completed a research rotation with the Center for Drug Evaluation and Research department at the FDA. His research interests are in multi-omics association studies on variations in treatment outcomes for pediatric leukemias and neonatology. He has presented his research at American Society of Hematology and American Society of Clinical Pharmacology and Therapeutic Annual Conferences.
- This course will give participants a broad perspective on the emergence of clinical and applied pharmacogenomics (PGx) and provide them with insight into its growing importance in major clinical therapeutic areas.
Outline the fundamentals of pharmacogenomics as a foundation for clinical implementation
Explore how pharmacogenomics connects to other aspects of clinical pharmacology
Discuss strategies and examples for developing a pharmacogenomics implementation program